ALS reports financial recovery
As expected, Brisbane-based global testing company ALS (ASX:ALQ) has ensured that its shareholders will not feel the financial pain of its Nuvisan adventure—the wasted millions of dollars invested in the European drug testing company and the quarter of a billion dollar impairment wrote down.
Read More